Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma
- GSK to present data from its innovative oncology portfolio at ESMO Congress 2019
- GSK announces positive headline results from the pivotal DREAMM-2 study for multiple myeloma
Tweets from GSK
-
GSK @GSK
Proud that our #malaria vaccine, RTS,S, has been made available by @MOH_Kenya and @WHO in Kenya, following Malawi and Ghana #EndMalaria twitter.com/WHO/status/117…
about 2 days ago
-
GSK @GSK
Congratulations to Magdalene Pedersen, Field VP, Pharma US and Head of GSK’s Women’s Leadership Initiative, who has been recognised as a @HERoesinB future leader of #WomenInBusiness, helping drive workplace gender equality forward. bit.ly/2nd63kE #HERRoleModels19 twitter.com/HERoesinB/stat…
about 3 days ago
-
GSK @GSK
We know genetically validated drug candidates are twice as likely to become registered novel medicines. Efforts like this bring us closer to developing transformational medicines that can significantly improve patient health and change lives.
about 4 days ago
